What is ACBM stock price today?

ACBM (ACRO Biomedical Co Ltd) stock is trading at $0.03 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACBM stock going up or down today?

ACBM stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACBM stock now?

The decision to buy ACBM depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACBM a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACBM based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACBM stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACBM is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACBM's P/E ratio?

P/E ratio data for ACBM will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACBM's market cap?

ACBM (ACRO Biomedical Co Ltd) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ACBM's price to book ratio?

ACBM trades at a price-to-book (P/B) ratio of 518.48, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACBM pay dividends?

ACBM does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACBM's dividend yield?

ACBM does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACBM stock a good long-term investment?

ACBM's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACBM's revenue growth rate?

ACBM has shown revenue growth of -0.9% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

ACBM is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in ACBM?

Key risks for ACBM include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACBM compare to its competitors?

Compare ACBM to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACBM's performance and positioning.

What is ACBM's stock price target for 2026?

Our AI model provides price targets for ACBM based on fundamental analysis: Bull case $0.03 (+30%), Base case $0.03 (+15%), Bear case $0.02 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACBM?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACBM. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACBM's next earnings report?

ACBM reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACBM - ACRO Biomedical Co Ltd

NYSE * Financial Services * Shell Companies

$0.03

+$0.00 (+0.00%)

About ACRO Biomedical Co Ltd

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

ACBM Key Statistics

Market Cap

$1.56M

P/B Ratio

518.48

Revenue Growth

-0.9%

Profit Margin

-1.9%

How ACBM Compares to Peers

ACBM is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACBM(This stock)	$1.56M	N/A	-1%	-1.9%	-
JPMJPMorgan Chase	$833.03B	14.9	0%	0.3%	vs JPM
BACBank of	$384.42B	13.4	0%	0.3%	vs BAC
WFCWells Fargo	$249.77B	12.6	0%	0.3%	vs WFC
GSGoldman Sachs	$322.33B	20.0	0%	0.3%	vs GS
VVisa Inc.	$608.90B	27.9	0%	0.5%	vs V

ACRO Biomedical Co Ltd Company Information

Headquarters: 12175 Visionary Way, Fishers, IN, United States, 46038, undefined
Website: acrobiomedicalco.com
Sector: Financial Services
Industry: Shell Companies

Data Updated: June 5, 2026 at 11:04 AM EDT

Ready to invest in ACBM?

Commission-free trading available. Affiliate links.

ACBM Lician Score

5% confidence

4.0/10

Neutral

ACBM has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACBMacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACBM Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACBM

Dashboard

Enter a ticker to analyze